Guardant Health Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Full Year 2020 Outlook

Go back to Guardant Health Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Full Year 2020 Outlook

Guardant Health (GH) Tops Q4 EPS by 5c, Offers Guidance

February 24, 2020 4:26 PM EST

Guardant Health (NASDAQ: GH) reported Q4 EPS of ($0.27), $0.05 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $62.9 million versus the consensus estimate of $54.83 million.

GUIDANCE:

Guardant Health sees FY2020 revenue of $275-285 million, versus the consensus... More